Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.
Klompas M, Branson R, Eichenwald EC, Greene LR, Howell MD, Lee G, Magill SS, Maragakis LL, Priebe GP, Speck K, Yokoe DS, Berenholtz SM; Society for Healthcare Epidemiology of America (SHEA). Klompas M, et al. Infect Control Hosp Epidemiol. 2014 Aug;35(8):915-36. doi: 10.1086/677144. Infect Control Hosp Epidemiol. 2014. PMID: 25026607 No abstract available.
Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB. Allewelt M, et al. Infect Immun. 2000 Jul;68(7):3998-4004. doi: 10.1128/iai.68.7.3998-4004.2000. Infect Immun. 2000. PMID: 10858214 Free PMC article.
Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine.
Priebe GP, Brinig MM, Hatano K, Grout M, Coleman FT, Pier GB, Goldberg JB. Priebe GP, et al. Infect Immun. 2002 Mar;70(3):1507-17. doi: 10.1128/iai.70.3.1507-1517.2002. Infect Immun. 2002. PMID: 11854239 Free PMC article.
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant.
Priebe GP, Meluleni GJ, Coleman FT, Goldberg JB, Pier GB. Priebe GP, et al. Infect Immun. 2003 Mar;71(3):1453-61. doi: 10.1128/iai.71.3.1453-1461.2003. Infect Immun. 2003. PMID: 12595463 Free PMC article.
Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
Kamei A, Coutinho-Sledge YS, Goldberg JB, Priebe GP, Pier GB. Kamei A, et al. Infect Immun. 2011 Mar;79(3):1289-99. doi: 10.1128/IAI.01139-10. Epub 2010 Dec 13. Infect Immun. 2011. PMID: 21149583 Free PMC article.
Topical neutralization of interleukin-17 during experimental Pseudomonas aeruginosa corneal infection promotes bacterial clearance and reduces pathology.
Zaidi TS, Zaidi T, Pier GB, Priebe GP. Zaidi TS, et al. Infect Immun. 2012 Oct;80(10):3706-12. doi: 10.1128/IAI.00249-12. Epub 2012 Jul 16. Infect Immun. 2012. PMID: 22802348 Free PMC article.
Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.
Kamei A, Wu W, Traficante DC, Koh AY, Van Rooijen N, Pier GB, Priebe GP. Kamei A, et al. J Infect Dis. 2013 Jan 1;207(1):39-49. doi: 10.1093/infdis/jis657. Epub 2012 Oct 24. J Infect Dis. 2013. PMID: 23100569 Free PMC article.
Vaccines for Pseudomonas aeruginosa: a long and winding road.
Priebe GP, Goldberg JB. Priebe GP, et al. Expert Rev Vaccines. 2014 Apr;13(4):507-19. doi: 10.1586/14760584.2014.890053. Epub 2014 Feb 27. Expert Rev Vaccines. 2014. PMID: 24575895 Free PMC article. Review.
52 results
Jump to page
Feedback